University of Alabama at Birmingham - Phase I Clinical Trials Unit — Birmingham, Alabama

University of Alabama at Birmingham - Phase I Clinical Trials Unit is a clinical research site located in Birmingham, Alabama, United States 35249.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

University of Alabama at Birmingham - Phase I Clinical Trials Unit has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Melanoma, Glioma, Thyroid Cancer.

Sponsors: Pfizer.

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Alabama at Birmingham - Phase I Clinical Trials Unit?

University of Alabama at Birmingham - Phase I Clinical Trials Unit has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Alabama at Birmingham - Phase I Clinical Trials Unit conducted?

University of Alabama at Birmingham - Phase I Clinical Trials Unit has 1 clinical trials on record, with 1 currently active. Their work covers Melanoma, Glioma, Thyroid Cancer.

Is University of Alabama at Birmingham - Phase I Clinical Trials Unit accredited by Crixeo Health?

University of Alabama at Birmingham - Phase I Clinical Trials Unit has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of Alabama at Birmingham - Phase I Clinical Trials Unit?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.